Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017–40: a population-based study-Reference-Cited by-同舟云学术

Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017–40: a population-based study

Published:2016-10 Issue:10 Volume:17 Page:1445-1452
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Vaccarella Salvatore,Franceschi Silvia,Zaridze David,Poljak Mario,Veerus Piret,Plummer Martyn,Bray Freddie

Funder

seventh framework programme of Directorate-General Research of the European Commission, through the CoheaHr Network

Publisher

Elsevier BV

Subject

Oncology

Reference43 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania;Arbyn;Int J Cancer,2011

3. Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors;Vaccarella;Eur J Cancer,2013

4. Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia;Bray;Vaccine,2013

5. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe;Poljak;Vaccine,2013

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IRTKS contributes to the malignant progression of cervical cancer cells;Medical Oncology;2024-06-13

2. Predictive modeling and web-based tool for cervical cancer risk assessment: A comparative study of machine learning models;MethodsX;2024-06

3. Evidence of Decreased Long-term Risk of Cervical Precancer after Negative Primary HPV Screens Compared with Negative Cytology Screens in a Longitudinal Cohort Study;Cancer Epidemiology, Biomarkers & Prevention;2024-05-22

4. Analysis of the global burden of cervical cancer in young women aged 15–44 years old;European Journal of Public Health;2024-05-16

5. IRTKS Contributes to the Malignant Progression of Cervical Cancer Cells;2024-03-20